This study aimed to elucidate the effects of intravenously infused magnesium on renal calcium and sodium metabolism in patients with essential hypertension. Mean arterial pressure (MAP), heart rate (HR), urine volume (UV), endogenous creatinine clearance (Ccr), urinary excretion of calcium (U
CaV) and sodium (U
NaV), fractional excretion of calcium (FE
Ca) and sodium (FE
NaV), plasma ionized calcium (pCa
2+) and parathyroid hormone(PTH) were measured before and after intravenous infusion of 10% magnesium sulfate (initial dose: Mg 13.5mg/m
2BSA/15 min.: maintenance dose: Mg 2.7mg/m
2 ·BSA/105min) in 6 normotensive subjects (NT) and 13 mild-to-moderate essential hypertensives (EHT). After the magnesium infusion, significant increases of UV, U
CaV, U
NaV, FEca and FE
Na, and a significant decrease of PTH were observed in both NT and EHT while MAP and HR did not change in either group. PCa
2+ significantly decreased and Ccr tended to increase only in EHT. Although no significant difference was found in the change in Ccr (ACcr) or PTH (Z PTH) between NT and EHT, the changes of U
CaV (Δ
CaV), U
NaV (ΔU
CaV), FE
Ca (ΔFE
Ca) and FE
Na (ΔFE
Na) were greater in EHT than each in NT. A positive correlation was found between ΔU
CaV and ΔFE
Ca, as well as ΔU
CaV and ΔC
Cr, but the former was more remarkable in both groups. In addition, ΔU
CaV was positively correlated with ΔFE
Na in EHT, but not in NT. No significant relationship was observed between ΔU
CaV and ΔPTH in either group. Thus, it is concluded that in EHT, the i. v. infusion of magnesium produces the enhanced calciuresis and natriuresis which might result from suppression of renal tubular reabsorption of calcium and sodium, and this suppression is partly related to the attenuation of plasma PTH. Furthermore, a possibility should be considered that the enhanced calciuretic response might contribute to the hypotensive mechanism of long-term magnesium loading in EHT.
抄録全体を表示